Status:
TERMINATED
Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.
Lead Sponsor:
Nantes University Hospital
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Comparison between FDG-PET and MRI for the assessment of response to intensive chemotherapy in multiple myeloma patients.
Detailed Description
First whole body FDG-PET scan and MRI before the start of the treatment. Second whole body FDG-PET scan and MRI after the end of the treatment. On a basis of patient, comparison between PET and MRI wi...
Eligibility Criteria
Inclusion
- Patients from 18 to 65 years old.
- De novo histologically proven multiple myeloma.
Exclusion
- No history of another cancer or of HIV
- No history of renal failure
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00200668
Start Date
March 1 2005
End Date
December 1 2006
Last Update
June 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France, 44093